Literature DB >> 8512108

Surfactant treatment of respiratory failure induced by hydrochloric acid aspiration in rats.

E P Eijking1, D Gommers, K L So, M Vergeer, B Lachmann.   

Abstract

BACKGROUND: The surfactant system seems to be involved in the pathophysiology of respiratory failure caused by hydrochloric acid (HCl) aspiration. This study was an investigation of the effect of different treatment strategies using an exogenous surfactant preparation on lung function of rats suffering from respiratory failure after intratracheal HCl instillation.
METHODS: In rats anesthetized with halothane, nitrous oxide, and oxygen, tracheotomy was performed and the lungs were mechanically ventilated. Respiratory failure was induced by intratracheal instillation of HCl (0.1 N, 3 ml/kg). After the PaO2 decreased to < 200 mmHg, the animals were randomly divided into five groups. Group I received no treatment; group II received a natural surfactant preparation intratracheally (200 mg/kg); group III underwent bronchoalveolar lavage (BAL) with saline, followed by surfactant treatment (200 mg/kg); and groups IV and V underwent BAL with saline and a diluted surfactant suspension (3.3 mg/ml in 30 ml/kg), respectively. Groups IV and V received a second and third BAL 60 and 120 min after the first lavage. Blood gas analysis and protein measurements in BAL fluids were performed.
RESULTS: Gas exchange improved in Groups III and V only. Protein concentrations were high in all BAL fluids. In the rats receiving BAL three times (groups IV and V), a decrease in protein concentration was observed.
CONCLUSIONS: From these results, it was concluded that plasma-derived proteins (which are known to inhibit surfactant function) are washed out of the alveoli by BAL, resulting in improved efficacy of surfactant treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512108     DOI: 10.1097/00000542-199306000-00019

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  9 in total

1.  Lavage administration of dilute surfactant in a piglet model of meconium aspiration.

Authors:  Joan Meister; Venkataraman Balaraman; Malia Ramirez; Catherine F T Uyehara; Jeffrey Killeen; Tercia Ku; Donald Person; David Easa
Journal:  Lung       Date:  2004       Impact factor: 2.584

2.  Tracheal acid or surfactant instillation raises alveolar surface tension.

Authors:  Tam L Nguyen; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2018-05-17

3.  Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation.

Authors:  Alexander Zarbock; Kai Singbartl; Klaus Ley
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

Review 4.  Aspiration-induced lung injury.

Authors:  Krishnan Raghavendran; Jean Nemzek; Lena M Napolitano; Paul R Knight
Journal:  Crit Care Med       Date:  2011-04       Impact factor: 7.598

5.  Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice.

Authors:  T Nagase; S Ishii; K Kume; N Uozumi; T Izumi; Y Ouchi; T Shimizu
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

6.  Interactions of pulmonary surfactant protein A with phospholipid monolayers change with pH.

Authors:  M L Ruano; K Nag; C Casals; J Pérez-Gil; K M Keough
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

7.  Effect of cyclooxygenase-2 inhibitor pretreatment on gas exchange after hydrochloric acid aspiration in rats.

Authors:  Yoshiaki Terao; Toshiaki Nakamura; Hiroaki Morooka; Koji Sumikawa
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

Review 8.  Aspiration syndromes and associated lung injury: incidence, pathophysiology and management.

Authors:  P Košutova; P Mikolka
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

9.  Surfactant lavage with lidocaine improves pulmonary function in piglets after HCl-induced acute lung injury.

Authors:  T K Huang; C F T Uyehara; V Balaraman; C Y Miyasato; D Person; E Egan; D Easa
Journal:  Lung       Date:  2004       Impact factor: 2.584

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.